AWARD
B -- Development and Production of Parenteral Dosage Forms for Clinical Studies
- Notice Date
- 1/23/2009
- Notice Type
- Award Notice
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd., EPS Suite 600, Rockville, Maryland, 20852
- ZIP Code
- 20852
- Solicitation Number
- N02-CM-77021-39
- Point of Contact
- Theresa H. Shroff,, Phone: (301) 228-4223
- E-Mail Address
-
ts144t@nih.gov
- Small Business Set-Aside
- N/A
- Award Number
- HHSN261200900006C
- Award Date
- 12/31/2008
- Awardee
- Ben Venue Laboratories, Inc., 300 Northfield Road<br />, Bedford, Ohio 44146, United States
- Award Amount
- $12,575,012, including all options
- Description
- The primary objective of this project is to develop and produce pharmaceutically acceptable parenteral dosage forms of promising new agents with activity against cancer. Data obtained from this contract may 1) be used to support IND applications submitted by the National Cancer Institute to the U.S. Food and Drug Administration as well as foreign agen¬cies, 2) be provided to other NCI contractors engaged in large scale dosage form manufacture and analytical evaluation of these dosage forms and 3) be provided to physicians, pharmacists, nurses, and other medical personnel handling these products in a clinical setting.
- Web Link
-
FedBizOpps Complete View
(https://www.fbo.gov/?s=opportunity&mode=form&id=217ff63b4685e29df89902b54622ea61&tab=core&_cview=1)
- Record
- SN01737139-W 20090125/090123223511-217ff63b4685e29df89902b54622ea61 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |